Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
10.1093/ofid/ofab387
Saved in:
Main Authors: | Stewart, AG, Paterson, DL, Young, B, Lye, DC, Davis, JS, Schneider, K, Yilmaz, M, Dinleyici, R, Runnegar, N, Henderson, A, Archuleta, S, Kalimuddin, S, Forde, BM, Chatfield, MD, Bauer, MJ, Lipman, J, Harris-Brown, T, Harris, PNA |
---|---|
其他作者: | MEDICINE |
格式: | Article |
出版: |
Oxford University Press (OUP)
2021
|
主題: | |
在線閱讀: | https://scholarbank.nus.edu.sg/handle/10635/206194 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |
相似書籍
-
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC β-lactamase-producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens : a pilot multicenter randomized controlled trial (MERINO-2)
由: Stewart, Adam G., et al.
出版: (2021) -
Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
由: Teo, Jocelyn Qi-Min, et al.
出版: (2022) -
Overexpression of AmpC Promotes Bacteriophage Lysis of Ampicillin-Resistant Escherichia coli
由: Wang, S., et al.
出版: (2021) -
Structure-based design of non-beta-lactam inhibitors for AMPC beta-lactamases
由: CHONG MIEN HAN
出版: (2010) -
CTX-M and ampC β-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore
由: Tan, T.Y., et al.
出版: (2011)